ATE236169T1 - Heterocyclisch kondensierte morphinoid-derivate - Google Patents

Heterocyclisch kondensierte morphinoid-derivate

Info

Publication number: ATE236169T1
Authority: AT; Austria
Prior art keywords: pct; heterocyclic condensed; sec; derivatives; morphinoid derivatives
Prior art date: 1994-07-14

Application number

AT95925855T

Other languages

English (en)

Inventor

Giulio Dondio

Silvano Ronzoni

Original Assignee

Glaxosmithkline Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-07-14

Filing date

1995-07-07

Publication date

2003-04-15

1995-07-07 Application filed by Glaxosmithkline Spa filed Critical Glaxosmithkline Spa

2003-04-15 Application granted granted Critical

2003-04-15 Publication of ATE236169T1 publication Critical patent/ATE236169T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Pulmonology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Toxicology (AREA)
Psychiatry (AREA)
Transplantation (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Saccharide Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

AT95925855T 1994-07-14 1995-07-07 Heterocyclisch kondensierte morphinoid-derivate ATE236169T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
ITMI941463A IT1270612B (it)	1994-07-14	1994-07-14	Derivati eterociclo-condensatori di morfinoidi
PCT/EP1995/002694 WO1996002545A1 (en)	1994-07-14	1995-07-07	Heterocycle-condensed morphinoid derivatives

Publications (1)

Publication Number	Publication Date
ATE236169T1 true ATE236169T1 (de)	2003-04-15

Family

ID=11369271

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT95925855T ATE236169T1 (de)	1994-07-14	1995-07-07	Heterocyclisch kondensierte morphinoid-derivate

Country Status (19)

Country	Link
US (1)	US5981540A (de)
EP (1)	EP0770081B1 (de)
JP (1)	JP3480936B2 (de)
CN (1)	CN1051086C (de)
AT (1)	ATE236169T1 (de)
AU (1)	AU686413B2 (de)
BR (1)	BR9508406A (de)
CA (1)	CA2194877A1 (de)
CZ (1)	CZ9897A3 (de)
DE (1)	DE69530205T2 (de)
ES (1)	ES2196069T3 (de)
HU (1)	HUT76812A (de)
IT (1)	IT1270612B (de)
MX (1)	MX9700373A (de)
NO (1)	NO315119B1 (de)
NZ (1)	NZ289858A (de)
PL (1)	PL182747B1 (de)
WO (1)	WO1996002545A1 (de)
ZA (1)	ZA955782B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5985880A (en)	1996-06-05	1999-11-16	Delta Pharmaceuticals	Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds
AR005423A1 (es) *	1996-01-10	1999-06-23	Smithkline Beecham Spa	Derivados morfinoides condensados con heterociclos (ii), su uso como sustancia terapeutica y para preparar medicamentos, composiciones farmaceuticasque los contienen y procedimiento para preparar dichos derivados.
US6103722A (en) *	1997-07-23	2000-08-15	The Medical College Of Wisconsin Research Foundation Inc.	Ischemic preconditioning
IT1312083B1 (it) *	1999-04-20	2002-04-04	Smithkline Beecham Spa	Derivati morfinoidi, procedimento per la loro preparazione e loroimpiego terapeutico.
DE60010891T2 (de)	1999-08-13	2005-06-09	Southern Research Institute, Birmingham	Pyridomorphinanen und ihre verwendung
AU6635800A (en) *	1999-08-13	2001-03-13	Southern Research Institute	Pyridomorphinans, thienomoprhinans and use thereof
US7015326B1 (en) *	1999-08-13	2006-03-21	Southern Research Institute	Pyridomorphinans, thienomorphinans and use thereof
GB0025056D0 (en) *	2000-10-12	2000-11-29	Smithkline Beecham Spa	Novel compounds
AU2004267994B8 (en) *	2003-08-27	2010-06-17	College Of Medicine - The University Of Arizona Health Sciences Center	Pyridomorphinans, pyridazinomorphinans and use thereof
CN104395317A (zh) *	2012-05-02	2015-03-04	南方研究所	杂环-稠合的吗啡喃、其用途及其制备
WO2014136305A1 (ja) *	2013-03-08	2014-09-12	学校法人北里研究所	モルヒナン誘導体
JP2017521488A (ja) *	2014-06-13	2017-08-03	パーデュー、ファーマ、リミテッド、パートナーシップ	複素環式モルフィナン誘導体及びその使用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5223507A (en) *	1992-01-21	1993-06-29	G. D. Searle & Co.	Method of using opioid compounds as delta opioid selective agonist analgesics
US5225417A (en) *	1992-01-21	1993-07-06	G. D. Searle & Co.	Opioid agonist compounds

1994
- 1994-07-14 IT ITMI941463A patent/IT1270612B/it active IP Right Grant
1995
- 1995-07-07 CA CA002194877A patent/CA2194877A1/en not_active Abandoned
- 1995-07-07 BR BR9508406A patent/BR9508406A/pt not_active IP Right Cessation
- 1995-07-07 AU AU29824/95A patent/AU686413B2/en not_active Ceased
- 1995-07-07 JP JP50467196A patent/JP3480936B2/ja not_active Expired - Fee Related
- 1995-07-07 HU HU9700073A patent/HUT76812A/hu unknown
- 1995-07-07 NZ NZ289858A patent/NZ289858A/en unknown
- 1995-07-07 DE DE69530205T patent/DE69530205T2/de not_active Expired - Fee Related
- 1995-07-07 EP EP95925855A patent/EP0770081B1/de not_active Expired - Lifetime
- 1995-07-07 CZ CZ9798A patent/CZ9897A3/cs unknown
- 1995-07-07 PL PL95318148A patent/PL182747B1/pl not_active IP Right Cessation
- 1995-07-07 WO PCT/EP1995/002694 patent/WO1996002545A1/en not_active Application Discontinuation
- 1995-07-07 MX MX9700373A patent/MX9700373A/es not_active IP Right Cessation
- 1995-07-07 ES ES95925855T patent/ES2196069T3/es not_active Expired - Lifetime
- 1995-07-07 US US08/776,134 patent/US5981540A/en not_active Expired - Fee Related
- 1995-07-07 CN CN95194912A patent/CN1051086C/zh not_active Expired - Fee Related
- 1995-07-07 AT AT95925855T patent/ATE236169T1/de not_active IP Right Cessation
- 1995-07-22 ZA ZA955782A patent/ZA955782B/xx unknown
1997
- 1997-01-13 NO NO19970142A patent/NO315119B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
ZA955782B (en)	1996-02-26
AU686413B2 (en)	1998-02-05
NO970142L (no)	1997-03-12
NO315119B1 (no)	2003-07-14
ITMI941463A0 (it)	1994-07-14
CZ9897A3 (en)	1997-07-16
IT1270612B (it)	1997-05-07
WO1996002545A1 (en)	1996-02-01
NZ289858A (en)	1998-01-26
NO970142D0 (no)	1997-01-13
DE69530205T2 (de)	2004-02-05
HUT76812A (en)	1997-11-28
ES2196069T3 (es)	2003-12-16
DE69530205D1 (de)	2003-05-08
BR9508406A (pt)	1997-12-23
US5981540A (en)	1999-11-09
PL318148A1 (en)	1997-05-12
EP0770081A1 (de)	1997-05-02
JPH10502657A (ja)	1998-03-10
HU9700073D0 (en)	1997-02-28
MX9700373A (es)	1998-03-31
JP3480936B2 (ja)	2003-12-22
AU2982495A (en)	1996-02-16
CA2194877A1 (en)	1996-02-01
ITMI941463A1 (it)	1996-01-14
CN1051086C (zh)	2000-04-05
CN1161041A (zh)	1997-10-01
EP0770081B1 (de)	2003-04-02
PL182747B1 (pl)	2002-02-28

Publication	Publication Date	Title
MY129596A (en)	2007-04-30	Quinoline derivatives as tachykinin nk3 receptor antagonists
BR9707136A (pt)	1999-08-31	Derivados morfinóides condesados em heterociclo (ii)
DE59708265D1 (de)	2002-10-24	Neue in 6-position substituierte phenanthridine
TR200202323T2 (tr)	2002-12-23	Akut akciğer harabiyeti ve fibrozitinin alfavß6 antagonistleriyle tedavisi
DE69530205D1 (de)	2003-05-08	Heterocyclisch kondensierte morphinoid-derivate
ID22042A (id)	1999-08-26	Benzonaftiridin sebagai pengobatan cabang tenggorokan
NZ329807A (en)	2000-07-28	NK-1 receptor antagonists and P receptor antagonists 2-Diarylmethyl-3-amino-1-azabicyclo[2.2.2]octane derivatives and amino substituted N-containing rings as agents for treating irritable bowel syndrome
NO982778D0 (no)	1998-06-16	Morfinderivater med smertestillende virkning
NZ300942A (en)	1998-12-23	1-aryl-2-acylamino-ethane derivatives as neurokinin 1 antagonists
DE59510713D1 (de)	2003-07-10	N-substituierte 3-azabicyclo(3.2.0)heptan-derivate als neuroleptika
TR200001102T2 (tr)	2000-08-21	İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
TR199800478T1 (xx)	1998-06-22	Diarilalkenilamin t�revleri
TR199901416T2 (xx)	1999-08-23	Heterosiklik karbonikasit t�revleri.
TR199901395T2 (xx)	1999-11-22	Yeni karboksi ikameli siklik karboksamid t�revleri.
MX9603199A (es)	1997-07-31	Antagonistas de receptores a endotelina.
SE9404438D0 (sv)	1994-12-21	New process
ATE294802T1 (de)	2005-05-15	3-alkylimidazopyridine
MXPA98005355A (es)	2004-10-28	Derivados de 5-[(heteroaril) alquil]-3 -oxo-pirido [1, 2-a]bencimidazol -4-carboxamida utiles en el tratamiento de trastornos del sistema nervioso central.
AR021502A1 (es)	2002-07-24	Uso de derivados de azabicicloalcanos n-sustituidos para el tratamiento de enfermedades del sistema central nervioso
DE69528288D1 (de)	2002-10-24	Indolderivate zur behandlung von migräne
ATE221068T1 (de)	2002-08-15	Anellierte beta-carboline

Legal Events

Date	Code	Title	Description
2003-10-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties